Synthesized boron compounds: Neurotoxic and oxidative effects in an in vitro model of Alzheimer's disease

dc.contributor.authorBayil, Sibel
dc.contributor.authorTozlu, Ozlem Ozdemir
dc.contributor.authorKaragul, Bora
dc.date.accessioned2026-07-01T11:39:42Z
dc.date.available2026-07-01T11:39:42Z
dc.date.issued2025
dc.departmentDüzce Üniversitesi
dc.description.abstractObjective Alzheimer's disease (AD) is characterized by amyloid-beta (A beta 1-42) aggregation, oxidative stress, and neuronal loss, necessitating novel therapeutic agents to mitigate these pathological hallmarks. Method This study investigates the neuroprotective and antioxidant properties of newly synthesized borenium (compounds 1-4) and borinium (compounds 5-8) derivatives in an in vitro AD model using differentiated SH-SY5Y neuroblastoma cells exposed to A beta 1-42. Furthermore, automated Total Antioxidant Capacity assays were conducted using commercially available kits on culture media collected from cell cultures following 24 h of incubation. 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide and lactate dehydrogenase tests were done to determine the cytotoxicity of boron compounds after application to the exposed cell lines of A beta 1-42. Results It was determined that the boron compounds applied to the cell lines at different concentrations did not show any neurotoxic effect at a concentration of 50 mu M in 24 h of incubation. All boron compounds were determined to have antioxidant properties. It was found that the borinium compounds are much more neuroprotective than the borenium. Conclusion These findings highlight the therapeutic potential of borenium and borinium compounds as neuroprotective and antioxidant agents for AD, warranting further mechanistic and in vivo studies.
dc.identifier.doi10.1177/00368504251384830
dc.identifier.issn0036-8504
dc.identifier.issn2047-7163
dc.identifier.issue4
dc.identifier.orcid0000-0003-0254-6915
dc.identifier.pmid41091796
dc.identifier.scopus2-s2.0-105018892842
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1177/00368504251384830
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23433
dc.identifier.volume108
dc.identifier.wosWOS:001595229800001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Ltd
dc.relation.ispartofScience Progress
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260623
dc.subjectA Beta 1-42
dc.subjectAlzheimer'S Disease
dc.subjectBoron Compounds
dc.subjectNeuroprotective
dc.subjectOxidative Effect
dc.titleSynthesized boron compounds: Neurotoxic and oxidative effects in an in vitro model of Alzheimer's disease
dc.typeArticle

Dosyalar